HUTCHMED (China) Dividends and Buybacks
Dividend criteria checks 0/6
HUTCHMED (China) does not have a record of paying a dividend.
Key information
n/a
Dividend yield
1.1%
Buyback Yield
| Total Shareholder Yield | 1.1% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Hutchmed Growing Sales By 64% In H1 2024
Aug 09Hutchmed Is Turning Profitable
Mar 20Hutchmed begins dosing in phase 2/3 trial of sovleplenib for red blood cell disorder
Oct 10Hutchmed, Inmagene begin dosing in phase 1 trial of potential autoimmune disease drug IMG-004
Aug 09Hutchmed begins dosing in mid-stage study of tazemetostat in blood cancer subtype
Aug 01Hutchmed begins dosing in early-stage study of cancer drug HMPL-A83
Jul 15Hutchmed, Inmagene begin dosing in early-stage study of IMG-007 for eczema
Jul 06Hutchmed Roils Markets With Changing Of Its Guard, U.S. Delisting Threat
Mar 11Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if HCM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HCM's dividend payments have been increasing.
Dividend Yield vs Market
| HUTCHMED (China) Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HCM) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (HCM) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate HCM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HCM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate HCM's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HCM has not reported any payouts.